Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern
Wenwei Li, Yaozong Chen, Jérémie Prévost, et al.
Cell Reports (2021) Vol. 38, Iss. 2, pp. 110210-110210
Open Access | Times Cited: 122

Showing 1-25 of 122 citing articles:

Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy
Irfan Ullah, Jérémie Prévost, Mark S. Ladinsky, et al.
Immunity (2021) Vol. 54, Iss. 9, pp. 2143-2158.e15
Open Access | Times Cited: 193
Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes
Jasmin Quandt, Alexander Muik, Nadine Salisch, et al.
Science Immunology (2022) Vol. 7, Iss. 75
Open Access | Times Cited: 187
Broadly neutralizing antibodies target the coronavirus fusion peptide
Cherrelle Dacon, Courtney Tucker, Linghang Peng, et al.
Science (2022) Vol. 377, Iss. 6607, pp. 728-735
Open Access | Times Cited: 187
Divergent SARS-CoV-2 variant emerges in white-tailed deer with deer-to-human transmission
Bradley Pickering, Oliver Lung, Finlay Maguire, et al.
Nature Microbiology (2022) Vol. 7, Iss. 12, pp. 2011-2024
Open Access | Times Cited: 181
A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection
Guillaume Beaudoin-Bussières, Yaozong Chen, Irfan Ullah, et al.
Cell Reports (2022) Vol. 38, Iss. 7, pp. 110368-110368
Open Access | Times Cited: 114
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease
Pan-Pan Zhou, Ge Song, Hejun Liu, et al.
Immunity (2023) Vol. 56, Iss. 3, pp. 669-686.e7
Open Access | Times Cited: 113
A large-scale systematic survey reveals recurring molecular features of public antibody responses to SARS-CoV-2
Yiquan Wang, Meng Yuan, Huibin Lv, et al.
Immunity (2022) Vol. 55, Iss. 6, pp. 1105-1117.e4
Open Access | Times Cited: 85
Antiviral Drug Discovery for the Treatment of COVID-19 Infections
Teresa I. Ng, Ivan Correia, Jane Seagal, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 961-961
Open Access | Times Cited: 77
SARS-CoV-2 Variants Increase Kinetic Stability of Open Spike Conformations as an Evolutionary Strategy
Ziwei Yang, Yang Han, Shilei Ding, et al.
mBio (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 70
Conformational dynamics and allosteric modulation of the SARS-CoV-2 spike
Marco A. Díaz-Salinas, Qi Li, Monir Ejemel, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 70
Identification of a conserved S2 epitope present on spike proteins from all highly pathogenic coronaviruses
Rui P. Silva, Yimin Huang, Annalee W. Nguyen, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 64
Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines
Chieh-Yu Liang, Saravanan Raju, Zhuoming Liu, et al.
Nature (2024) Vol. 630, Iss. 8018, pp. 950-960
Closed Access | Times Cited: 29
Molecular basis of convergent evolution of ACE2 receptor utilization among HKU5 coronaviruses
Young‐Jun Park, Chen Liu, Jimin Lee, et al.
Cell (2025)
Closed Access | Times Cited: 3
Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses
Alexandra Tauzin, Shang Yu Gong, Guillaume Beaudoin-Bussières, et al.
Cell Host & Microbe (2021) Vol. 30, Iss. 1, pp. 97-109.e5
Open Access | Times Cited: 97
Contribution of single mutations to selected SARS-CoV-2 emerging variants spike antigenicity
Shang Yu Gong, Debashree Chatterjee, Jonathan Richard, et al.
Virology (2021) Vol. 563, pp. 134-145
Open Access | Times Cited: 85
Highly divergent white-tailed deer SARS-CoV-2 with potential deer-to-human transmission
Bradley Pickering, Oliver Lung, Finlay Maguire, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 62
SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses
Debashree Chatterjee, Alexandra Tauzin, Lorie Marchitto, et al.
Cell Reports (2022) Vol. 38, Iss. 9, pp. 110429-110429
Open Access | Times Cited: 55
Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses
Mingxi Li, Yifei Ren, Zhen Qin Aw, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 46
Structural Plasticity and Immune Evasion of SARS-CoV-2 Spike Variants
Dibya Ghimire, Yang Han, Maolin Lu
Viruses (2022) Vol. 14, Iss. 6, pp. 1255-1255
Open Access | Times Cited: 43
Protective neutralizing epitopes in SARS‐CoV‐2
Hejun Liu, Ian A. Wilson
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 76-92
Open Access | Times Cited: 39
Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses
Cherrelle Dacon, Linghang Peng, Ting-Hui Lin, et al.
Cell Host & Microbe (2022) Vol. 31, Iss. 1, pp. 97-111.e12
Open Access | Times Cited: 39
SARS-CoV-2 spike S2-specific neutralizing antibodies
Chia‐Jung Li, Shih‐Chung Chang
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 33
Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine
Alexandra Tauzin, Alexandre Nicolas, Shilei Ding, et al.
Cell Reports (2023) Vol. 42, Iss. 1, pp. 111998-111998
Open Access | Times Cited: 22
Structure and inhibition of SARS-CoV-2 spike refolding in membranes
Michael W. Grunst, Zhuan Qin, Esteban Dodero‐Rojas, et al.
Science (2024) Vol. 385, Iss. 6710, pp. 757-765
Closed Access | Times Cited: 13
Intra-Host Evolution Analyses in an Immunosuppressed Patient Supports SARS-CoV-2 Viral Reservoir Hypothesis
Dominique Fournelle, Fatima Mostefai, Elsa Brunet‐Ratnasingham, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 342-342
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top